Parnaparin
Clinical data | |
---|---|
ATC code | |
Identifiers | |
CAS Number | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
WikiDoc Resources for Parnaparin |
Articles |
---|
Most recent articles on Parnaparin |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Parnaparin at Clinical Trials.gov Clinical Trials on Parnaparin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Parnaparin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Parnaparin Discussion groups on Parnaparin Patient Handouts on Parnaparin Directions to Hospitals Treating Parnaparin Risk calculators and risk factors for Parnaparin
|
Healthcare Provider Resources |
Causes & Risk Factors for Parnaparin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Parnaparin is an antithrombotic agent. It is a low molecular weight hepain.
External Links
- parnaparin at the US National Library of Medicine Medical Subject Headings (MeSH)
Additional Resource
- Maugeri N, Di Fabio G, Barbanti M, de Gaetano G, Donati MB, Cerletti C (2007). "Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood". Thromb. Haemost. 97 (6): 965–73. PMID 17549299.
References
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- CS1 maint: Multiple names: authors list
- Drug
- Cardiovascular Drugs
- Anticoagulants